Literature DB >> 17476024

Alendronate and atrial fibrillation.

Steven R Cummings, Ann V Schwartz, Dennis M Black.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476024     DOI: 10.1056/NEJMc076132

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  60 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

2.  Bisphosphonates and risk of atrial fibrillation: a meta-analysis.

Authors:  Seo Young Kim; Min Jung Kim; Suzanne M Cadarette; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2010-02-19       Impact factor: 5.156

3.  Oral bisphosphonates and atrial fibrillation.

Authors:  Sumit R Majumdar
Journal:  BMJ       Date:  2008-03-11

Review 4.  Adverse effects of bisphosphonates: implications for osteoporosis management.

Authors:  Kurt A Kennel; Matthew T Drake
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 5.  Bisphosphonates pathway.

Authors:  Li Gong; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2011-01       Impact factor: 2.089

6.  Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

Review 7.  Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application.

Authors:  Raymond E Cole; Steven T Harris
Journal:  Medscape J Med       Date:  2009-01-13

Review 8.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

Review 9.  Diagnosis and management of osteoporosis in the older senior.

Authors:  Sheryl F Vondracek; Sunny A Linnebur
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

10.  Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.

Authors:  Anselm Mak; Mike W L Cheung; Roger Chun-Man Ho; Alicia Ai-Cia Cheak; Chak Sing Lau
Journal:  BMC Musculoskelet Disord       Date:  2009-09-21       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.